OptimizeRx price target lowered to $8 from $16 at JMP Securities
JMP Securities lowered the firm’s price target on OptimizeRx (OPRX) to $8 from $16 and keeps an Outperform rating on the shares.
OptimizeRx (OPRX) Gets a Buy from Stifel Nicolaus
In a report released today, David Grossman from Stifel Nicolaus maintained a Buy rating on OptimizeRx (OPRX – Research Report), with a ...
bovnews50m
What’s Fueling Savara Inc (SVRA) Stock’s -26.56% Loss Below Its 200-Day SMA?
On Wednesday, Savara Inc (SVRA) stock saw a decline, ending the day at $3.25 which represents a decrease of $-0.58 or -15.14% from the prior close of $3.83. The stock opened at $3.67 and touched a low ...